Sign Up For Mailing List Button

Donate to Genetic Alliance

Disease Search Button

NETS - Phase III Clinical Trials (Safety, Efficacy)

Facebook icon
Google+ icon
Twitter icon
LinkedIn icon
Del.icio.us icon
Digg icon
  • Partnerships
  • Publications
  • Multimedia
  • Worksheets
  • Guides
  • Toolkits
  • Databases
  • Services

What are Phase III clinical trials and why are they important in drug development?

Phase III clinical trials are large studies which confirm drug safety and efficacy. They contain a greater number of participants than Phase II trials so that safety and efficacy can be validated in a larger population. The trials almost always randomly assign participants to one of two groups, the control group or the treatment group. Phase III trials usually include participants of different race, ethnicity and gender, in order to see how a drug acts on a diverse group of people.

Testimonials: How we did it

Content not yet available for this section.

Relevant Publications

Content not yet available for this section.

 

Twitter icon
Facebook icon
LinkedIn icon
Google+ icon
YouTube icon
RSS icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.